Related references
Note: Only part of the references are listed.A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression
Umi M. Abd Hamid et al.
GLYCOBIOLOGY (2008)
Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon
Adrian M. Di Bisceglie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation
James N. Arnold et al.
PROTEOMICS (2008)
N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus
Xue-En Liu et al.
HEPATOLOGY (2007)
Fucosylation of N-glycans regulates the secretion of hepatic glycoproteins into bile ducts
Tsutomu Nakagawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Hepatocellular carcinoma
JA Marrero
CURRENT OPINION IN GASTROENTEROLOGY (2006)
Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma
MA Comunale et al.
JOURNAL OF PROTEOME RESEARCH (2006)
Comprehensive glyco-proteomic analysis of human alpha(1)-antitrypsin and its charge isoforms
Daniel Kolarich et al.
PROTEOMICS (2006)
GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma
JA Marrero et al.
JOURNAL OF HEPATOLOGY (2005)
Hepatocellular carcinoma: Epidemiology risk factors, and screening
M Sherman
SEMINARS IN LIVER DISEASE (2005)
Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans
TM Block et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Risk factors for hepatocellular carcinoma in patients with cirrhosis
SA Sarbah et al.
DIGESTIVE DISEASES AND SCIENCES (2004)
Molecular viral oncology of hepatocellular carcinoma
TM Block et al.
ONCOGENE (2003)
Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States
HB El-Serag et al.
HEPATOLOGY (2001)
Share Paper
